{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:10:18Z","timestamp":1761808218050,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aimed to investigate the potential of preoperative mammographic breast density (MBD) as a prognostic factor in breast cancer. Data of 969 patients with primary breast cancer were analyzed. We defined low MBD as fatty or fibroglandular breast, and high MBD as heterogeneously dense or extremely dense breast, respectively. The high MBD group demonstrated a superior overall survival rate compared to the low MBD group (p\u2009&lt;\u20090.001). Favorable prognostic effects of high MBD were observed in subgroups aged &gt;50 years (p\u2009&lt;\u20090.001) and with positive hormone receptor (HRc) and negative human epidermal growth factor receptor 2 (HER2) (p\u2009&lt;\u20090.001). The high MBD group had a higher proportion of patients aged \u226450 years (p\u2009&lt;\u20090.001) and patients with body mass index (BMI) \u226425\u2009kg\/m<jats:sup>2<\/jats:sup> (p\u2009&lt;\u20090.001), and a higher proportion of patients who received chemotherapy (p\u2009&lt;\u20090.001). MBD was a significant independent prognostic factor by multivariable analysis (hazard ratio, 0.382; 95% confidence interval, 0.206\u20130.708). The high MBD group was associated with superior overall survival rates. Preoperative MBD was a strong independent prognostic factor in operable primary invasive female breast cancer, especially in patients with age &gt;50 years and the HRc(+)\/HER2(\u2212) subtype. Favorable clinicopathologic features, active treatments, and other factors could contribute to this causality.<\/jats:p>","DOI":"10.1038\/s41598-018-34297-8","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T15:43:32Z","timestamp":1540395812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic Influence of Preoperative Mammographic Breast Density in Operable Invasive Female Breast Cancer"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6597-3119","authenticated-orcid":false,"given":"Ki-Tae","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Jung","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jongjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hyun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young A.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwoong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumjo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"key":"34297_CR1","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2214\/ajr.126.6.1130","volume":"126","author":"JN Wolfe","year":"1976","unstructured":"Wolfe, J. N. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 126, 1130\u20137 (1976).","journal-title":"AJR Am J Roentgenol"},{"key":"34297_CR2","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1002\/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8","volume":"37","author":"JN Wolfe","year":"1976","unstructured":"Wolfe, J. N. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37, 2486\u201392 (1976).","journal-title":"Cancer"},{"key":"34297_CR3","unstructured":"Sickles E. A. et al. ACR BI-RADS Mammography. In: D\u2019Orsi, C.J., Sickles, E.A., Mendelson, E.B., Morris, E.A., et al. ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, VA: American College of Radiology (2013)."},{"key":"34297_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1056\/NEJMp020093","volume":"347","author":"E Thurfjell","year":"2002","unstructured":"Thurfjell, E. Breast density and the risk of breast cancer. N Engl J Med 347, 866 (2002).","journal-title":"N Engl J Med"},{"key":"34297_CR5","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","volume":"15","author":"VA McCormack","year":"2006","unstructured":"McCormack, V. A. & dos Santos Silva, I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15, 1159\u201369 (2006).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"34297_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S1470-2045(05)70390-9","volume":"6","author":"NF Boyd","year":"2005","unstructured":"Boyd, N. F. et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6, 798\u2013808 (2005).","journal-title":"Lancet Oncol"},{"key":"34297_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJMoa062790","volume":"356","author":"NF Boyd","year":"2007","unstructured":"Boyd, N. F. et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 356, 227\u201336 (2007).","journal-title":"N Engl J Med"},{"key":"34297_CR8","doi-asserted-by":"publisher","first-page":"dju425","DOI":"10.1093\/jnci\/dju425","volume":"107","author":"SJ Nyante","year":"2015","unstructured":"Nyante, S. J. et al. Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer. J Natl Cancer Inst 107, dju425 (2015).","journal-title":"J Natl Cancer Inst"},{"key":"34297_CR9","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1200\/JCO.2012.44.5015","volume":"31","author":"J Li","year":"2013","unstructured":"Li, J. et al. Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol 31, 2249\u201356 (2013).","journal-title":"J Clin Oncol"},{"key":"34297_CR10","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00330-015-3626-2","volume":"25","author":"A Masarwah","year":"2015","unstructured":"Masarwah, A. et al. Very low mammographic breast density predicts poorer outcome in patients with invasive breast cancer. Eur Radiol 25, 1875\u201382 (2015).","journal-title":"Eur Radiol"},{"key":"34297_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2892-y","volume":"16","author":"A Masarwah","year":"2016","unstructured":"Masarwah, A. et al. Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer. BMC Cancer 16, 833 (2016).","journal-title":"BMC Cancer"},{"key":"34297_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0096-3","volume":"31","author":"S Elsamany","year":"2014","unstructured":"Elsamany, S. et al. Prognostic value of mammographic breast density in patients with metastatic breast cancer. Med Oncol 31, 96 (2014).","journal-title":"Med Oncol"},{"key":"34297_CR13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1158\/1055-9965.EPI-09-1028","volume":"19","author":"SY Chiu","year":"2010","unstructured":"Chiu, S. Y. et al. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev 19, 1219\u201328 (2010).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"34297_CR14","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/jnci\/djs327","volume":"104","author":"GL Gierach","year":"2012","unstructured":"Gierach, G. L. et al. Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst 104, 1218\u201327 (2012).","journal-title":"J Natl Cancer Inst"},{"key":"34297_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3378","volume":"15","author":"G Maskarinec","year":"2013","unstructured":"Maskarinec, G. et al. Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort. Breast Cancer Res 15, R7 (2013).","journal-title":"Breast Cancer Res"},{"key":"34297_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3450","volume":"15","author":"L Eriksson","year":"2013","unstructured":"Eriksson, L., Czene, K., Rosenberg, L., Humphreys, K. & Hall, P. Possible influence of mammographic density on local and locoregional recurrence of breast cancer. Breast Cancer Res 15, R56 (2013).","journal-title":"Breast Cancer Res"},{"key":"34297_CR17","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2214\/AJR.06.0619","volume":"188","author":"MG del Carmen","year":"2007","unstructured":"del Carmen, M. G. et al. Mammographic breast density and race. AJR Am J Roentgenol 188, 1147\u201350 (2007).","journal-title":"AJR Am J Roentgenol"},{"key":"34297_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1047-2797(00)00225-8","volume":"11","author":"AY El-Bastawissi","year":"2001","unstructured":"El-Bastawissi, A. Y., White, E., Mandelson, M. T. & Taplin, S. Variation in mammographic breast density by race. Ann Epidemiol 11, 257\u201363 (2001).","journal-title":"Ann Epidemiol"},{"key":"34297_CR19","doi-asserted-by":"publisher","first-page":"W292","DOI":"10.2214\/AJR.10.6049","volume":"198","author":"CM Checka","year":"2012","unstructured":"Checka, C. M., Chun, J. E., Schnabel, F. R., Lee, J. & Toth, H. The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 198, W292\u20135 (2012).","journal-title":"AJR Am J Roentgenol"},{"key":"34297_CR20","doi-asserted-by":"publisher","first-page":"e0165409","DOI":"10.1371\/journal.pone.0165409","volume":"11","author":"HL Chen","year":"2016","unstructured":"Chen, H. L., Zhou, M. Q., Tian, W., Meng, K. X. & He, H. F. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database. PLoS One 11, e0165409 (2016).","journal-title":"PLoS One"},{"key":"34297_CR21","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1200\/JCO.2016.68.4480","volume":"34","author":"S Jiralerspong","year":"2016","unstructured":"Jiralerspong, S. & Goodwin, P. J. Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities. J Clin Oncol 34, 4203\u201316 (2016).","journal-title":"J Clin Oncol"},{"key":"34297_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/annonc\/mdh222","volume":"15","author":"G Berclaz","year":"2004","unstructured":"Berclaz, G. et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 15, 875\u201384 (2004).","journal-title":"Ann Oncol"},{"key":"34297_CR23","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","volume":"25","author":"DS Chan","year":"2014","unstructured":"Chan, D. S. et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 25, 1901\u201314 (2014).","journal-title":"Ann Oncol"},{"key":"34297_CR24","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1002\/cncr.24638","volume":"115","author":"T Cil","year":"2009","unstructured":"Cil, T. et al. Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery. Cancer 115, 5780\u20137 (2009).","journal-title":"Cancer"},{"key":"34297_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijrobp.2008.04.007","volume":"73","author":"CC Park","year":"2009","unstructured":"Park, C. C., Rembert, J., Chew, K., Moore, D. & Kerlikowske, K. High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer. Int J Radiat Oncol Biol Phys 73, 75\u20139 (2009).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"34297_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0784-3","volume":"18","author":"YS Huang","year":"2016","unstructured":"Huang, Y. S. et al. High mammographic breast density predicts locoregional recurrence after modified radical mastectomy for invasive breast cancer: a case-control study. Breast Cancer Res 18, 120 (2016).","journal-title":"Breast Cancer Res"},{"key":"34297_CR27","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/cncr.30573","volume":"123","author":"A Raghavendra","year":"2017","unstructured":"Raghavendra, A. et al. Mammographic breast density is associated with the development of contralateral breast cancer. Cancer 123, 1935\u201340 (2017).","journal-title":"Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34297-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34297-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34297-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:00:06Z","timestamp":1671620406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34297-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34297"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34297-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,10,30]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16075"}}